BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gąbka-Buszek A, Kwiatkowska-Borowczyk E, Jankowski J, Kozłowska AK, Mackiewicz A. Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a Murine Tumor Rejection Model. Vaccines (Basel) 2020;8:E147. [PMID: 32224883 DOI: 10.3390/vaccines8020147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Qiao Y, Agboola OS, Hu X, Wu Y, Lei L. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine. Stem Cell Rev Rep 2020;16:1049-61. [PMID: 32939647 DOI: 10.1007/s12015-020-10042-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
2 Hayat H, Hayat H, Dwan BF, Gudi M, Bishop JO, Wang P. A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy. Onco Targets Ther 2021;14:2761-72. [PMID: 33907419 DOI: 10.2147/OTT.S260391] [Reference Citation Analysis]
3 Salah A, Wang H, Li Y, Ji M, Ou WB, Qi N, Wu Y. Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications. Front Cell Dev Biol 2021;9:686544. [PMID: 34262904 DOI: 10.3389/fcell.2021.686544] [Reference Citation Analysis]
4 Krog RT, de Miranda NFCC, Vahrmeijer AL, Kooreman NG. The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2021;13:5789. [PMID: 34830945 DOI: 10.3390/cancers13225789] [Reference Citation Analysis]
5 Ouyang X, Liu Y, Zhou Y, Guo J, Wei TT, Liu C, Lee B, Chen B, Zhang A, Casey KM, Wang L, Kooreman NG, Habtezion A, Engleman EG, Wu JC. Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. Stem Cell Reports 2021;16:1468-77. [PMID: 33961792 DOI: 10.1016/j.stemcr.2021.04.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bernardes de Jesus B, Neves BM, Ferreira M, Nóbrega-Pereira S. Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines. Cancers (Basel) 2020;12:E3581. [PMID: 33266109 DOI: 10.3390/cancers12123581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang H, Wang Y, Wang Y. MiR-222-3p inhibits formation of medulloblastoma stem-like cells by targeting Notch2/c-myc signaling pathway. Immunopharmacol Immunotoxicol 2022;:1-18. [PMID: 35379056 DOI: 10.1080/08923973.2022.2062381] [Reference Citation Analysis]